MediPharm Labs Corp (MEDIF)

[FUNMAN]

MADD, I-wondered-the-same-thing...MediPharm Labs Corp. Presenting at the Benzinga Cannabis Capital Conference in Chicago

Tue October 15, 2019 2:35 PM|Newsfile|About: ACB, MEDIF

https://seekingalpha.com/pr/17663326-medipharm-labs-corp-presenting-benzinga-cannabis-capital-conference-chicago

Chicago, Illinois--(Newsfile Corp. - October 15, 2019) - MediPharm Labs Corp. (MEDIF) (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ), will be presenting at the 5th Benzinga Cannabis Capital Conference in Chicago October 22-23 before an audience of well-vetted public and private companies, and an audience of fellow institutional, family office and accredited investors looking for the right opportunities in a crowded and volatile market. Investment opportunities abound.

For more information and/or to register for the conference please visit: https://benzingacannabisconference.com/chicago/?utm_source=newsfile&utm_medium=press_release&utm_campaign=newsfile

Past and future Cannabis Capital Conferences will have heard from luminaries making headlines and disrupting the industry, including:

Bruce Linton | Executive Chairman at Gage Cannabis
Kevin Murphy | Chairman & CEO at Acreage Holdings (ACRZF)
Charlie Bachtell | CEO & Co-Founder at Cresco Labs (CRLBF)
Kim Rivers | CEO at Trulieve
Hadley Ford | CEO at iAnthus
Brian Schinderle | CFO at Grassroots
Gary Allen | COO at New Frontier Data
Will Stuart | SVP at Harvest One
Josh Genderson | Founder & CEO at Holistic Industries
Rob Kelly | Director of IR at Aurora Cannabis (ACB)
Peter Miller | CEO at SLANG Worldwide (SLGWF)

The 5th Benzinga Cannabis Capital Conference in Chicago October 22-23 is the premier gathering of cannabis entrepreneurs and investors in North America. No other conference offers the level of access and seamlessness of interaction between entrepreneurs building future billion-dollar cannabis enterprises and the investors whose capital will make that happen.

About MediPharm Labs Corp.

MediPharm Labs Corp., together with its subsidiaries, produces and sells pharma-grade cannabis oil and concentrates for derivative products in Canada and Australia. It also provides cannabis contract processing services to licensed producers and growers; and tolling services to Canadian licensed cultivators of cannabis for selling cannabis oil, formulations, and derivatives under their own brand. In addition, the company supplies purified cannabis concentrate raw materials and product formulations for ready-to-sell advanced cannabis products. Further, it engages in the real estate business. The company was founded in 2015 and is headquartered in Barrie, Canada.